109 related articles for article (PubMed ID: 18426337)
1. Analysis of the immune responses in chimpanzees infected with HIV type 1 isolates.
Juompan LY; Hutchinson K; Montefiori DC; Nidtha S; Villinger F; Novembre FJ
AIDS Res Hum Retroviruses; 2008 Apr; 24(4):573-86. PubMed ID: 18426337
[TBL] [Abstract][Full Text] [Related]
2. The impact of HIV-1 infection on phenotypic and functional parameters of cellular immunity in chimpanzees.
Ferrari G; Ottinger J; Place C; Nigida SM; Arthur LO; Weinhold KJ
AIDS Res Hum Retroviruses; 1993 Jul; 9(7):647-56. PubMed ID: 8369169
[TBL] [Abstract][Full Text] [Related]
3. Human and simian immunodeficiency virus-infected chimpanzees do not have increased intracellular levels of beta-chemokines in contrast to infected humans.
Ondoa P; Vereecken C; Fransen K; Colebunders R; van der Groen G; Heeney JL; Kestens L
J Med Virol; 2003 Mar; 69(3):297-305. PubMed ID: 12526038
[TBL] [Abstract][Full Text] [Related]
4. Loss of CD4+ T cells in human immunodeficiency virus type 1-infected chimpanzees is associated with increased lymphocyte apoptosis.
Davis IC; Girard M; Fultz PN
J Virol; 1998 Jun; 72(6):4623-32. PubMed ID: 9573225
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection--correlation with clinical progression, viral load, and loss of humoral immunity.
Samuelsson A; Broström C; van Dijk N; Sönnerborg A; Chiodi F
Virology; 1997 Nov; 238(2):180-8. PubMed ID: 9400591
[TBL] [Abstract][Full Text] [Related]
6. Studies on V3-specific cross-reactive T-cell responses in chimpanzees chronically infected with HIV-1IIIB.
Nehete PN; Murthy KK; Satterfield WC; Arlinghaus RB; Sastry KJ
AIDS; 1995 Jun; 9(6):567-72. PubMed ID: 7662194
[TBL] [Abstract][Full Text] [Related]
7. Disease progression markers during asymptomatic phase of HIV-1 infected children with unimpaired CD4+ cell values: evaluation of repeat CD4+ cell evaluation vs. other immunological parameters.
Chattopadhya D; Baveja UK; Bose M; Kumar A
J Trop Pediatr; 2002 Dec; 48(6):340-7. PubMed ID: 12521275
[TBL] [Abstract][Full Text] [Related]
8. Immune and hematopoietic parameters in HIV-1-infected chimpanzees during clinical progression toward AIDS.
Villinger F; Brar SS; Brice GT; Chikkala NF; Novembre FJ; Mayne AE; Bucur S; Hillyer CD; Ansari AA
J Med Primatol; 1997; 26(1-2):11-8. PubMed ID: 9271184
[TBL] [Abstract][Full Text] [Related]
9. Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses.
Salgado M; Garcia-Minambres A; Dalmau J; Jiménez-Moyano E; Viciana P; Alejos B; Clotet B; Prado JG; Martinez-Picado J
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593044
[TBL] [Abstract][Full Text] [Related]
10. Immune strategies utilized by lentivirus infected chimpanzees to resist progression to AIDS.
Heeney J; Bogers W; Buijs L; Dubbes R; ten Haaft P; Koornstra W; Niphuis H; Nara P; Teeuwsen V
Immunol Lett; 1996 Jun; 51(1-2):45-52. PubMed ID: 8811344
[TBL] [Abstract][Full Text] [Related]
11. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.
Barouch DH; Santra S; Schmitz JE; Kuroda MJ; Fu TM; Wagner W; Bilska M; Craiu A; Zheng XX; Krivulka GR; Beaudry K; Lifton MA; Nickerson CE; Trigona WL; Punt K; Freed DC; Guan L; Dubey S; Casimiro D; Simon A; Davies ME; Chastain M; Strom TB; Gelman RS; Montefiori DC; Lewis MG; Emini EA; Shiver JW; Letvin NL
Science; 2000 Oct; 290(5491):486-92. PubMed ID: 11039923
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids.
Boyer JD; Cohen AD; Ugen KE; Edgeworth RL; Bennett M; Shah A; Schumann K; Nath B; Javadian A; Bagarazzi ML; Kim J; Weiner DB
AIDS; 2000 Jul; 14(11):1515-22. PubMed ID: 10983638
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.
Dyer WB; Zaunders JJ; Yuan FF; Wang B; Learmont JC; Geczy AF; Saksena NK; McPhee DA; Gorry PR; Sullivan JS
Retrovirology; 2008 Dec; 5():112. PubMed ID: 19077215
[TBL] [Abstract][Full Text] [Related]
14. Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzees.
Beaumont T; Broersen S; van Nuenen A; Huisman HG; de Roda Husman AM; Heeney JL; Schuitemaker H
J Virol; 2000 Sep; 74(17):7699-707. PubMed ID: 10933675
[TBL] [Abstract][Full Text] [Related]
15. Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype.
Gougeon ML; Lecoeur H; Boudet F; Ledru E; Marzabal S; Boullier S; Roué R; Nagata S; Heeney J
J Immunol; 1997 Mar; 158(6):2964-76. PubMed ID: 9058836
[TBL] [Abstract][Full Text] [Related]
16. HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humans.
Williams KL; Cortez V; Dingens AS; Gach JS; Rainwater S; Weis JF; Chen X; Spearman P; Forthal DN; Overbaugh J
EBioMedicine; 2015 Oct; 2(10):1464-77. PubMed ID: 26629541
[TBL] [Abstract][Full Text] [Related]
17. Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses.
Liu SL; Schacker T; Musey L; Shriner D; McElrath MJ; Corey L; Mullins JI
J Virol; 1997 Jun; 71(6):4284-95. PubMed ID: 9151816
[TBL] [Abstract][Full Text] [Related]
18. DNA vaccination as anti-human immunodeficiency virus immunotherapy in infected chimpanzees.
Boyer JD; Ugen KE; Chattergoon M; Wang B; Shah A; Agadjanyan M; Bagarazzi ML; Javadian A; Carrano R; Coney L; Williams WV; Weiner DB
J Infect Dis; 1997 Dec; 176(6):1501-9. PubMed ID: 9395361
[TBL] [Abstract][Full Text] [Related]
19. Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses.
Nara PL; Robey WG; Arthur LO; Asher DM; Wolff AV; Gibbs CJ; Gajdusek DC; Fischinger PJ
J Virol; 1987 Oct; 61(10):3173-80. PubMed ID: 2442411
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal study of humoral immune responses in HIV type 1 subtype CRF01_AE (E)-infected Thai patients with different rates of disease progression.
Chuenchitra T; Wasi C; Louisirirojchanakul S; Nitayaphan S; Sutthent R; Cox JH; De Souza MS; Brown AE; Birx DL; Polonis VR
AIDS Res Hum Retroviruses; 2003 Apr; 19(4):293-305. PubMed ID: 12804005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
